Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 87 clinical trials
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata

makes a mistake and attacks the body. Some people with APECED have a type of hair loss called alopecia areata (AA). No drugs are approved to treat AA. Objective To

Accepts healthy volunteers
graft-versus-host disease
bilateral tubal ligation
areata alopecia
cervical cap
  • 20 views
  • 02 Jul, 2022
  • 1 location
PBMT for the Management of CIA ( HAIRLASER )

-induced alopecia (CIA) occurs in about 65% of the patients. Hair loss due to CT is reversible, but hair regrowth requires several months to a year after CT. Currently, the only available preventive

scalp cooling
paclitaxel
docetaxel
anthracycline
breast cancer
  • 0 views
  • 08 Apr, 2022
  • 1 location
Tofacitinib for Immune Skin Conditions in Down Syndrome

People with Down syndrome (DS) display widespread immune dysregulation, including several immune skin conditions. This study hypothesizes that pharmacological inhibition of the increased interferon (IFN) signaling seen in DS is safe and could improve associated skin conditions. The study evaluates the safety and efficacy treatment with Tofacitinib, an FDA-approved drug …

dermatitis
psoriasis
vitiligo
tofacitinib
hidradenitis
  • 88 views
  • 17 Jun, 2022
  • 1 location
Using a Cold Atmospheric Plasma Device to Treat Skin Disorders

This study examines the efficacy of a non-thermal, atmospheric plasma device in the treatment of skin disorders

skin disorders
acne
cold
hair loss
skin lesion
  • 206 views
  • 20 Apr, 2022
  • 1 location
Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer Patients

This study aims to examine whether the PSCS2 is effective in reducing chemotherapy-induced alopecia in woman with breast cancer undergoing neoadjuvant or adjuvant chemotherapy. Female adults who

adjuvant chemotherapy
adriamycin
taxane
  • 0 views
  • 20 Aug, 2021
  • 1 location
Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia

An open label, pilot study involving the use of low dose oral minoxidil to treat permanent chemotherapy-induced alopecia.

  • 63 views
  • 14 Jun, 2022
  • 1 location
Effect of Helmet Type, Home-use Low-level Light Therapy Device for Chemotherapy-induced Alopecia

-induced alopecia (CIA) affects up to 65% of the patients. This condition is reversible. Nevertheless, it takes several months after CT for visible hair regrowth. Different characteristics of the new hair

paclitaxel
docetaxel
taxane
  • 0 views
  • 19 Jun, 2022
  • 1 location
Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients

This study is being done to determine if using the Paxman Scalp Cooling System at temperatures lower than the current standard is a safe and tolerable approach to prevent hair loss in breast

anthracyclines
adjuvant chemotherapy
breast cancer stage i
immunostimulant
cyclophosphamide
  • 12 views
  • 01 Jul, 2022
  • 1 location
Scalp Cooling in MBC

This research is being done to compare rates of hair loss of people with metastatic breast who use scalp cooling versus those who do not use scalp cooling after receiving standard of care

  • 0 views
  • 23 Mar, 2022
  • 2 locations
A Study to Evaluate JAK Inhibitor Cream in EGFR-inhibitor-induced Skin Rash

any clinical trial yet. Janus kinase (JAK) inhibitor, has been approved for or studied in a variety of skin conditions such as alopecia areata, atopic dermatitis, and psoriasis. Thus the investigators

  • 0 views
  • 05 Jul, 2022
  • 1 location